News for Healthier Living

Tiny Materials, Stronger Antitumor Immunity

Cancer immunotherapy has changed the treatment landscape, yet many tumors still evade immune attack by hiding antigens, blocking T cell entry, and building an immunosuppressive tumor microenvironment (TME). A new review brings these scattered barriers into one mechanistic framework, showing how engineered nanomaterials can be designed to intervene across the cancer-immunity cycle. Rather than acting only as drug carriers, nanoparticles (NPs) can help deliver antigens and immune stimulants, improve antigen presentation, support T cell priming and infiltration, and reshape hostile tumor niches. The review provides a practical design map for developing more precise, durable, and safer nano-immunotherapies.

May 18, 2026


May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026